Sponsored by Saxo

Good morning.

On Stock head today, Guy Le Page summons the ghost of Elvis, a tempting junior uranium sandwich, and who’s our momentum trader of the week, we hear you say? IT’S ONLY PAUL TUDOR JONES!

 

COMMODITY/FOREX/CRYPTO MARKET PRICES

Gold: US$2,159.84 (+0.55%)

Silver: US$24.32 (+0.65%)

Nickel (3mth): US$17,717/t (-0.25%)

Copper (3mth): US$8,577/t (+1%)

Oil (WTI): US$79.44 (+0.40%)

Oil (Brent): US$83.28 (+0.40%)

Iron 62pc Fe: US$117.96/t (+0.85%)

AUD/USD: 0.6621 (+0.90%)

Bitcoin: US$67,518 (+1.85%)

 

WHAT GOT YOU TALKING

That’s gold, that is:

 

ASX SMALL CAP LEADERS

Friday’s best performing small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin

Magmatic Resources (ASX:MAG) says a farm-in and Joint Venture Agreement has been executed with Fortescue (ASX:FMG) at the Myall Project. Fortescue will spend up to $14m over six years to earn up to 75% joint venture interest in the project. Fortescue will also subscribe for 75,946,151 shares in MAG shares at a price of $0.04884 per share  to hold a 19.9% stake in the company.

OpenLearning (ASX:OLL) says it’s signed a three-year platform SaaS and content licence deal with the Asia Pacific International College. OLL says the minimum value is $1.07 million. APIC is a higher education institution with campuses in Sydney, Melbourne and Brisbane that offers undergraduate and postgraduate degree courses to over 4,000 students per year.

Imricor Medical Systems (ASX:IMR) says the Ethics Committee at Lausanne University Hospital (CHUV) has approved its VISABL-AFL clinical trial. This is the first of two approvals required for CHUV to join the trial. The final approval required is from Swissmedic, the competent authority in Switzerland. VISABL-AFL is the global trial to support US FDA approval of Imricor’s products.

And Pointerra (ASX:3DP) has been awarded a contract from U.S. energy utility customer worth US$1.9 million ($2.9 million). The company’s AI driven analytics platform will be used to extract information and insight from 3D LiDAR and imagery data. Pointerra  expects to complete contract deliverables this year.

 

 

ASX SMALL CAP LAGGARDS

Today’s best performing small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort

Wordpress Table Plugin

Juno Minerals’ (ASX:JNO) Phase 2 Priority 1 drill program has been completed with all assay results now being received. From the assay results reported, low levels of lithium, tantalum and tin were recorded, with no significant intersections of lithium encountered. The lithium pathfinder element data from the assay results will now be modelled to inform the next exploration phase on the Mount Ida Lithium Prospect.

 

TRADING HALTS

Ramelius Resources (ASX:RMS) – response to media speculation.